Frequency-domain features
CWT extracts low-amplitude signals invisible to conventional ECG analysis — the patterns AI excels at.
MyoVista wavECG
A 12-lead ECG built for the AI era.
MyoVista wavECG is a portable, clinical-grade ECG device that combines conventional 12-lead diagnostic information with proprietary signal processing — designed to host AI-ECG algorithms directly on the device.
Device
Two tests in one.
Every wavECG recording produces a complete conventional 12-lead ECG with the highly-acclaimed Glasgow interpretive analysis, plus wavelet-domain features that AI-ECG algorithms can act on directly.
- Full-featured 12-lead resting ECG
- Glasgow interpretive analysis included
- Software-upgradable to host future AI-ECG algorithms
- Direct cloud sync to MyoVista Insights
Why CWT
Continuous wavelet transform — proprietary signal processing.
The wavECG device extracts proprietary frequency- and energy-domain features from the ECG that conventional analysis can't see.
Cardiac relaxation
The first AI-ECG algorithm slated for the wavECG submission targets impaired cardiac relaxation.
Future-ready
Architected so additional AI-ECG models — aortic stenosis, mitral regurgitation, and more — drop in over the air.
Get started
See wavECG in your clinic.
Walk through the platform with our team and see how it fits the ECG management problem you're trying to solve.